Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,212 | 556 | -9,522 | 1,668 | 988 |
| Depreciation Amortization | 360 | 167 | 1,732 | 1,317 | 891 |
| Income taxes - deferred | N/A | N/A | -6,750 | N/A | N/A |
| Accounts receivable | -815 | -439 | -1,569 | -1,111 | -1,042 |
| Accounts payable and accrued liabilities | -600 | -931 | 689 | 550 | 610 |
| Other Working Capital | -870 | -1,446 | 5,985 | 1,456 | 852 |
| Other Operating Activity | 2,130 | 1,737 | 18,354 | 1,695 | 1,334 |
| Operating Cash Flow | $1,417 | $-357 | $8,920 | $5,575 | $3,633 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,210 | -458 | -6,839 | -5,124 | -1,833 |
| Purchase Of Investment | -855 | -744 | -1,083 | -1,083 | -1,083 |
| Sale Of Investment | 902 | 861 | 577 | 577 | 539 |
| Purchase Sale Intangibles | -933 | N/A | -800 | -533 | -400 |
| Other Investing Activity | -933 | 0 | -800 | -533 | -400 |
| Investing Cash Flow | $-3,096 | $-341 | $-8,145 | $-6,163 | $-2,777 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,200 | 950 | 950 | 950 | N/A |
| Debt Repayment | -78 | -41 | -156 | -116 | -77 |
| Common Stock Repurchased | -1,408 | -170 | -799 | -799 | -792 |
| Other Financing Activity | 28 | -200 | -2,068 | -568 | -568 |
| Financing Cash Flow | $1,742 | $539 | $-2,073 | $-532 | $-1,436 |
| Beginning Cash Position | 406 | 406 | 1,704 | 1,704 | 1,704 |
| End Cash Position | 469 | 247 | 406 | 584 | 1,124 |
| Net Cash Flow | $63 | $-159 | $-1,298 | $-1,120 | $-580 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,417 | -357 | 8,920 | 5,575 | 3,633 |
| Capital Expenditure | -2,210 | -458 | -6,839 | -5,124 | -1,833 |
| Free Cash Flow | -793 | -815 | 2,081 | 451 | 1,800 |